Epstein Secrets

althcare and life-sciences industry with a valuation of less than $750 million. The Fund expects to primarily invest in companies headquartered in North America. General Partner Biosys Capital Management, LLC, a Delaware limited liability company (the "General Partner"). Minimum Capital Commitment: Gene

terial compliance costs and other burdens. While the General Partner believes that the Fund will not be subject to the registration requirements of the U.S. Investment Company Act of 1940, as amended (the "Investment Company Act"), there can be no assurance that this belief is, or will continue to be, correct. If the Fund were

he healthcare industry with a pre-money valuation of less than $500 million. We expect the companies the Fund invests in to be located primarily in North America. $150 million in commitments ("Capital Commitments") from qualified investors; provided that the General Partner reserves the right to form the Fu

terial compliance costs and other burdens. While the General Partner believes that the Fund will not be subject to the registration requirements of the U.S. Investment Company Act of 1940, as amended (the "Investment Company Act"), there can be no assurance that this belief is, or will continue to be, correct. If the Fund were

Blackstone, Mr. Karim was a partner at Simpson Thacher & Bartlett LLP where he worked on a variety of real estate transactions in Asia, Europe, and North America. Mr. Karim received a BA (Honors) from McGill University and both a Master in International Affairs and a JD from Columbia University. A.J. Agarwa

e Partnership may be considered similar in some ways to an investment company, the Partnership is not required and does not intend to register under the U.S. Investment Company Act of 1940, as amended from time to time (the "1940 Act"), and, accordingly, Limited Partners are not afforded the protections of the 1940 Act. Indem